NCT00832494View on ClinicalTrials.gov

Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

DMXAA in combination with carboplatin and paclitaxel

Administered every 21 days

Sponsors

Lead Sponsor

Antisoma Research

All Listed Sponsors

lead

Antisoma Research

INDUSTRY